|
|
Article: Monkey see, monkey ....... don't! Rather than mirror big pharma, and capitalize on their losses, we must come up with remedies that truly do what drugs cannot do.(HEALTHCARE PRACTITIONER CORNER)
- Article from:
- Nutraceuticals World
- Article date:
- March 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 Rodman Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Findings from the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) study showing that the cholesterol-lowering combo-drug Vytorin (Zetia plus Zocor) did not reverse coronary artery atherosclerosis, despite the expected lowering of LDL cholesterol, have sent shockwaves through the medical community.
Cardiologists, shaking their heads in disbelief, are struggling to explain the results, while primary care doctors struggle with what to tell their suddenly suspicious patients. The public relations wings of Merck and Schering-Plough, the joint owners of Vytorin, are no doubt burning the midnight oil trying to find a ...